Skip to the stories
Daily Oracles

What changes next, and what it costs

Just published
Companies

Applied Nutrition revenue rises 51% to £161.6m as it plans for about £205m this year

The Knowsley sports nutrition group expects its enlarged Merseyside factory to be finished before Christmas, and is holding back dividends until its 2028 financial year to pay for growth.

By Daily Oracles News Team2 min read

A scoop of powder sitting on top of a table
Photograph: Alex Saks on Unsplash

Applied Nutrition, the sports nutrition company based in Knowsley, Merseyside, reported revenue of £161.6m for the year to 31 July, up 50.9% from £107.1m. Adjusted EBITDA rose 40.1% to £43.3m and statutory profit before tax was £41.0m, up from £28.5m.

The company repeated the guidance it gave earlier for the current year: revenue of about £205m and adjusted EBITDA of about £49m. It said trading in the first quarter had been very strong but that it was too early in the year to raise expectations.

Sales grew in every region. The UK brought in £70.3m, up 45.2%, and Europe £20.9m, up 34.0%. The rest of the world, which includes established markets in the Middle East, rose 63.3% to £70.4m, slightly more than the UK.

All the major UK grocers now stock its products, and sales through them rose 180%. It also signed its first licensing deal, with Morrisons, for a range of high-protein foods aimed at people taking GLP-1 weight-loss medicines. The company cited research from the Institute of Grocery Distribution showing GLP-1 use among UK consumers rising from 3.1% in June 2025 to 6% in March 2026.

What it is spending on

A production extension, new distribution centre and head office are being built in Knowsley, and management expects the extension to be finished before Christmas. Once complete, the UK site should be able to support about £300m of annual revenue. Until then the company is using off-site storage, and staff working on the extra internal logistics are expected to be redeployed by the third quarter of the financial year.

In June it bought the trade and most of the assets of Nutrablend, a US manufacturer in Buffalo, New York, for £11.9m. That plant has capacity for about $300m of revenue a year and contributed £1.6m of sales before the year end.

Costs and cash

The company has planned for a slightly lower EBITDA margin this year. US sales carry thinner margins because more of them are white-label products, and it expects whey protein to cost more on average than last year, even though prices have recently been easing. Whey-based products are also making up a bigger share of sales after the relaunch of its Critical Whey range.

Free cash flow fell to £10.6m from £16.5m. Working capital rose faster than revenue, mainly because the company held more stock, some of it linked to the US acquisition. Year-end net cash was £15.9m. No dividend was paid in the year, against £14.7m the year before, and the board does not expect to declare another before the 2028 financial year. It said it would look at a buyback or dividend if cash later builds up beyond what the business needs.

Read next

Know about a change before it lands?

Businesses, councils, charities and readers tell us about new prices, plans and launches. If it will change what people pay or how they work, we want to hear it.

Submit your story